Evidence map›Paper›PMID 27109359›Full record

ArticleNature communications2016

Identifying genetically driven clinical phenotypes using linear mixed models.

Jonathan D Mosley, John S Witte, Emma K Larkin, Lisa Bastarache, Christian M Shaffer, Jason H Karnes, C Michael Stein, Elizabeth Phillips, Scott J Hebbring, Murray H Brilliant and 4 more

Abstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Defining Phenotypes from Clinical Data to Drive Genomic Research.Annual review of biomedical data science · 2018
    Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jonathan D MosleyDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
John S WitteDepartment of Epidemiology and Biostatistics, University of California, San Francisco, California 94158, USA.
Emma K LarkinDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
Lisa BastaracheBiomedical Informatics, Vanderbilt University, Nashville, Tennessee 37203, USA.
Christian M ShafferDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
Jason H KarnesDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
C Michael SteinDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
Elizabeth PhillipsDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
Scott J HebbringCenter for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin 54449, USA.
Murray H BrilliantCenter for Human Genetics, Marshfield Clinic Research Foundation, Marshfield, Wisconsin 54449, USA.
John MayerBiomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin 54449, USA.
Zhan YeBiomedical Informatics Research Center, Marshfield Clinic Research Foundation, Marshfield, Wisconsin 54449, USA.ORCID 0000-0002-0426-0382
Dan M RodenDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
Joshua C DennyDepartment of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
Vanderbilt Genome-Electronic Records ProjectU01HG004603 · NHGRI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2007 to 2011
$7.3M
VESPA: Vanderbilt Electronic Systems for Pharmacogenomic AssessmentRC2GM092618 · NIGMS · VANDERBILT UNIVERSITY · PI DENNY, JOSHUA C., RODEN, DAN M · 2009 to 2010
$6.4M
From GWAS to PheWAS: Scanning the EMR Phenome for Gene-disease AssociationsR01LM010685 · NLM · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BASTARACHE, LISA · 2011 to 2022
$6.3M
VGER, the Vanderbilt Genome-Electronic Records ProjectU01HG008672 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENNY, JOSHUA C., RODEN, DAN M · 2015 to 2019
$5.1M
PheWAS of Loss-of-Function VariantsR01GM114128 · NIGMS · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI HEBBRING, SCOTT JOSEPH · 2015 to 2019
$1.7M
Drug Metabolism Genotypes in Clinical PracticeR01GM109145 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STEIN, CHARLES M. · 2014 to 2018
$1.1M
Development and Application of Phenome-wide Scan of Heritability (PheSH)K22LM011938 · NLM · MARSHFIELD CLINIC RESEARCH FOUNDATION · PI HEBBRING, SCOTT JOSEPH · 2014 to 2016
$405k
American Heart Association-American Stroke Association 16FTF30130005NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1 TR000445NHGRI NIH HHS U01 HG004603NHGRI NIH HHS U01 HG008672NIGMS NIH HHS R01 GM109145NIGMS NIH HHS R01 GM114128NIGMS NIH HHS RC2 GM092618NLM NIH HHS K22 LM011938NLM NIH HHS R01 LM010685
6 · The paper itself

Abstract

We hypothesized that generalized linear mixed models (GLMMs), which estimate the additive genetic variance underlying phenotype variability, would facilitate rapid characterization of clinical phenotypes from an electronic health record. We evaluated 1,288 phenotypes in 29,349 subjects of European ancestry with single-nucleotide polymorphism (SNP) genotyping on the Illumina Exome Beadchip. We show that genetic liability estimates are primarily driven by SNPs identified by prior genome-wide association studies and SNPs within the human leukocyte antigen (HLA) region. We identify 44 (false discovery rate q<0.05) phenotypes associated with HLA SNP variation and show that hypothyroidism is genetically correlated with Type I diabetes (rG=0.31, s.e. 0.12, P=0.003). We also report novel SNP associations for hypothyroidism near HLA-DQA1/HLA-DQB1 at rs6906021 (combined odds ratio (OR)=1.2 (95% confidence interval (CI): 1.1-1.2), P=9.8 × 10(-11)) and for polymyalgia rheumatica near C6orf10 at rs6910071 (OR=1.5 (95% CI: 1.3-1.6), P=1.3 × 10(-10)). Phenome-wide application of GLMMs identifies phenotypes with important genetic drivers, and focusing on these phenotypes can identify novel genetic associations.

Indexed as

Genetic Predisposition to DiseaseAdultAgedAged, 80 and overDiseaseExomeFemaleGenetic VariationGenome-Wide Association StudyGenotypeHLA AntigensHumansMaleMiddle AgedModels, GeneticPhenotypeHLA Antigens

Identifiers

PMID27109359
PMCPMC4848547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.